FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation
- Details
- Category: FDA
The U.S. Food and Drug Administration approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
FDA expands use of Xarelto to treat, reduce recurrence of blood clots
- Details
- Category: FDA
The U.S. Food and Drug Administration expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.
FDA takes action against thousands of illegal Internet pharmacies
- Details
- Category: FDA
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 4,100 Internet pharmacies that illegally sell potentially dangerous, unapproved drugs to consumers. Actions taken include civil and criminal charges, seizure of illegal products, and removal of offending websites.
FDA approves new treatment for advanced colorectal cancer
- Details
- Category: FDA
The U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).
New FDA task force will support innovation in antibacterial drug development
- Details
- Category: FDA
The U.S. Food and Drug Administration announced the formation of an internal task force that will support the development of new antibacterial drugs, a critical public health care goal and a priority for the agency.
FDA approves Lucentis to treat diabetic macular edema
- Details
- Category: FDA
The U.S. Food and Drug Administration today approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes.
FDA approves first generic versions of Singulair to treat asthma, allergies
- Details
- Category: FDA
The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.
More Pharma News ...
- More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief
- European Medicines Agency website on suspected side effect reports now in all 23 EU official languages
- European Medicines Agency boosts EU transparency
- FDA approves generic versions of blood thinner Plavix
- FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
- FDA approves first Boniva generics to treat or prevent osteoporosis
- FDA announces safety changes in labeling for some cholesterol-lowering drugs